Focused on solving unmet needs in ophthalmology

Addressing significant unmet medical needs for better topical therapy
image/svg+xml TABLEAU_OCULIS modif 2020-02-05T10:20:37+01:00 2020-02-05T10:20:37+01:00 2020-02-05T10:20:37+01:00 Adobe Illustrator 24.0 (Macintosh) 256 92 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAXAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9U4q7FXYq7FXYq7FWIv+ WejfUEsIb7ULe0VDH6UU4ClSqKagqw3KFiOlWbbpSXEikZH5JtUZ3Op6hI7RNCrvMhKI8bxfAeAI ID15daqCe9RaUOfy9s2ld5NW1OQO3JomnT0/t86cBHxpXDxIpZ/yrbTPXkmGp6kpkJPFZ1AVmQx8 lonUIeIJ7Y8S0yqGIRQxxBmYRqFDOeTHiKVY9zkUpRq/lW01K+N613d2s5hWCtrL6QojOytShqwM hpX+uEFUqvfy2sriCZE1XUY5JB+6d5hKI2DmQFQy12Yjv2GHiRS+2/LqziSr6rqL3DenznEwVv3b cuKfCWVak7Vrv1rvjxLS+L8vrBOXPU9Rn5RiJTNOrlAG51Q8NjUdcFrTj+X1h6rzDU9REzp6Qk9Z CyoF4hVLRnbvv3oe2NrS1fy6sEgSJNV1NOIIaRbhVdyWD8nYJ8R5D8flQ8S0mPl/yvDoskrx3c9z 6qRxkTFSFEYptQDbvTxJ8cBKVXU9Ds9YsoIbtpFEEhmiaJuDCQI6KwahNV58l9wPliCqAh8jWkLL Iup6iZljEaytOGIIJPqcSvAtvTdae2NqhYfy202IPTU9SYsrhWadCUMh5Myfu9mLfFXxw8SKT/Rd Hj0q2lgjubi6WWVpud1J6rqXA+FWIHw7dMBKVZrdLrTTbSEhJ4fTcr1o68TStd98CscP5caYrR/V NR1GyhjIItredVjJVQtWDIxOwFd8lxIpPNH0SDSoViinnuCsaxGW5k9WRgryOCzEVJrKfopgJSjF r9Yfw4J+tsCpFqXkfS77ULnUfrF1a3t1tJPbyhGC+ksIVaqwACr95PtQ2tIc/l7pz2VzZz6jqNxF dIschmnDkBZhOCoKceXIUqR02x4kUyW4r6LU67frwJSvV/Kum6reLeTvNFdJF6MU0L8GQcufJdvt cqfdhBVAWfkKztpOZ1TUrgFJYzHPcBkImj9NiVCAGgNV7A42ik307SrfSdJttOtmd4bcqqNIQXIM ldyoUd/DAUpZrvnay0bVIbC4tZ5DK0Q9ZAhUCb1KEKW5sF9I8iFoKjxwgItAXP5p6BbwzyPb3fKK oRPS3dvTMnFd/wDJofA0r1GHhW1S8/M3QLK4vIbyK5i+pTPA8gRXVmQMWKcWJIHDfbbatCaY8K2n Xl7zHp+v2b3diJBCj+mfVQoa8Vfb2owwEUlFatePZaVe3saCR7aCWZEPRjGhYDbxpjEWaYzNAl8i ap5k17Vb2W9vr6aa4lYsxLsAK9lUGigdgM30ccYigHjsmpyTNklP7Hyre3Vpa3H6ZYfWY1f0ow8j ryKCvFWqyJ6nxkCoIIocpllAJFObDSzlEHjO/wCO/wCaje+UJora5uJ9XjMkEtxCsTOHd/q8TS9Y 3kVSwjI4k7Gnc4Y5d6phPSkAkz5X9gvvYyl3dIKJNIo8FYj9Ry/hDgjJIciV31++/wCWmX/g2/rj wjuT4s+8q9jfXxvrcG4lp6qftt/MPfIyiKZ4ssuIbnmzzzH5Z1HVvNGu3cesQWUS6pPbejPM6MAt HMlBtwAbfMXHkEYgVezs82nnkySIlwjipL5/Ieq28avN5htgWC1VJnfizBzxJWo/3X16bjJDPE/w sDopjnNQtfJer3E1xEuuW6G29Iu0k7KrCYV5If2lX9ojCc0R/Cxjo8hJHHy825vJOuRmZF1iGWSG J5Qkc7HmyCojjNfiZqGnuDiM0e5To8g/j+1UfyJrCTxwnXrVi4lPKO4Z1HpIr9V2+LlQe4OPjx/m p/JZLrj+1Xf8utaWJpF8w2TkHiFFywrV3QUrTfkgr4VwfmI/zU/kcn8/7WIamdQsNQuLNr0zGCRk E0UrNG4B2dGrurDcZkRoi6dfllOEjHiO3mhvr99/y0S/8G39clwjuYeLPvLvr99/y0y/8G39ceEd y+LPvLvr99/y0y/8G39ceEdy+LPvLvr99/y0y/8ABt/XHhHcviz7y76/ff8ALRL/AMG39ceEdy+L PvLvr99/y0y/8G39ceEdy+LPvLvr99/y0y/8G39ceEdy+LPvLvr99/y0S/8ABt/XHhHcviz7y76/ ff8ALTL/AMG39ceEdy+LPvL6w/L1mbyPoTMSzGyhJY7kngM0ef6z73rtKbxR/qhPLmnotX2/XlTk KmKuxVTn+wP9dP8AiYxVUxV2KtSRpIjRyKHjcFXRhUEHYgg4q5EREVEUKigKqqKAAbAADFW2VWUq wBUihB3BBxV81+btK/KKPW7lNP1W9hQO3qRW0C3ECtXdYnZ4jxB+Y8Dm3xSy8O4DzWox6XjNSI93 JJf0d+W3/V61L/pBi/6r5ZxZe4fNp8PTfzpfJQmsfy/D0j1jUitOv1CE7/TdJ+rCJZO4fP8AY1yh g6Sl/pf2r4bD8uyv7zWNSDV/5YIh+q5f9eJlk7h82UYafrKXyVP0d+W3/V61L/pBi/6r4OLL3D5s vD0386XyVrPT/wAuRdwFNZ1Ev6i8QbKMAnkKf7vwSlkrkPmyx49PxCpS59ya+eLHyE/m/WGvdVv4 rtruUzxR2cbor8jUKxmUke9MrwyycAoD5t2rhgOWXFKV33JJ+jvy2/6vWpf9IMX/AFXy3iy9w+bj +Hpv50vk79Hflt/1etS/6QYv+q+PFl7h818PTfzpfJ36O/Lb/q9al/0gxf8AVfHiy9w+a+Hpv50v k79Hflt/1etS/wCkGL/qvjxZe4fNfD0386Xyd+jvy2/6vWpf9IMX/VfHiy9w+a+Hpv50vk79Hflt /wBXrUv+kGL/AKr48WXuHzXw9N/Ol8mhp/5b031nUgf+YKP/AKr48WXuHzXw9N/Ol8m/0d+W3/V6 1L/pBi/6r48WXuHzXw9N/Ol8nfo78tv+r1qX/SDF/wBV8eLL3D5r4em/nS+Tv0d+W3/V61L/AKQY v+q+PFl7h818PTfzpfJoaf8AlvQV1nUge4+ox/8AVfHiy9w+a+Hpv50vk3+jvy2/6vWpf9IMX/Vf Hiy9w+a+Hpv50vk79Hflt/1etS/6QYv+q+PFl7h818PTfzpfJk3k78q/K3m1LqTStbu1SzKLKZ7V ENZORFKSt/LlOXUzhzAcrT9n4soJjI7eTJP+hb7H/q+y/wDSOv8A1Uyr8+e5yP5Gh/OL1Xy/pK6P oljpSyGZbKFIBKRxLBBStKmmYM5cRJ73a4sfBER7gi7j+5b6P15FsVMVdiqncfYH+un/ABMYqqYq 7FXYq7FUJrFtPdaRfW1u3Cee3lihatKO6FVNe25yUTRDGYsEB8c3tld2N3LZ3kLQXUDFJoXFGVh2 IzfxkCLDxM4GJo7EMksvMfliKytYZdJUzxRhZZzHFLyIKFgVbiW58GqxPJeVFIyiWOdndzoajEIg GO/uH43/ALFObzD5aNtdxQ6QBJPLcPHNIIiyJLE6xheCRheMjK1AKALt1wjHKxuxlqMVECPO+7u2 +1jGXuC7FURYf73W3/GVP+JDBLkWzF9Y97PvMGv+W9O84a9Fqmhpqc/6UnkEzPxpGaAJShr8QJ+n MSGORgKNbOzzZ8cMshKPEeJK7HzT5JgStz5aF1MeDsTKET1FjRWUKqj4C8fOn+URk5Yp9JNUNVgH OFrJfNPk8wkQeW0jnEarHKZA4EihuTlGUq3Ln09lwjFP+cp1WHpBdfeavJdzFdRxeWEtvWNYJEmq 8Q5P0+ED7LDr39gBgGKY/iWWqwkEeG3eebPJktrOkHlaOGeWCWOOQTGiSymqyCqn+7JPEdSNq4jF O/qRPVYSDWPel0Pm3yUJmkm8qxOD6gVFlKrR+KrUU6qsYII/aLHvicU/5yRqsF74/wAfj9KhbeaP KawSwXHl1JOasscyyBXQszty+weRCsqjem3ywnFP+cgarDyMFa081+SYJHEnldLiJmlYepNRh6jV AHFR9hSVXfsD1rgOKZ/iTHVYB/k7U73zV5Qms5IoPLMcNwxfjOJegZlZRx4noKjanb3wjFO/qRPV YSNsaofN/k83ay/4WjWEE1g9YEGqBKk+kD3ZqCgrx96jwZ19SfzeG/7sfj4KaeZvJkUFrCnlwP8A V2iMs0stXmEZq3Oi0HPka022GHwp/wA5A1OEADg5Kv8Ai/yaYI0PlWISISWkWUVaqt4px6v/AC9h 3weDP+cy/N4a/u0LrnmbyzeadJbafoMVlcOXIuqgsoaXmoAAA+GOqe/XrkoY5A2TbXm1OKUSIwo9 7FcvcB7n/wA43/7xa7/xkt/+IyZrNfzD0PY30S972XMB3LsVU7j+5b6P14qqYq7FVOf7A/10/wCJ jFVTFXYq7FXYqo3t3DZ2c93MSIbaN5ZSBU8UUs1B8hhAs0gmhb5q8w/nD5g1bUHnW0sY7cEiCKW1 huGVOwLyq5J8aUHtm3hpIgcy8zl7UnI7AV7rVLfW/P8AcRQyw6XpzRzgGJjZWC8uRUKvxKPibmvF erV2wGGMdT8y2RzaggERjv5BDPqnne5Se4Gm6a0dsZY5WFhprDlApeQKTGxaiqT8Na0NOhwiMBtZ +ZazPPKzwx28o9Eth/MHXIl4rb6aRWv/ABzrIf8AEYlyw6eJ7/mWmOvmOkf9KFT/AJWPr3/LNpv/ AHD7T/qng/Lx8/my/lDJ3R+StZ/mLrr3cCG206jSKDTT7QHdh39PBLTxrr82WPXzMgKjz7mR+a/M PnBvNWsRadplrc20F7LAkp0+3lYlWGzO0ZZm+MVrlOPHDhFnp3uXnzZvEkIxBAPclx1b8xwXB0K1 rHy5j9F2tV4fbr+72498lwY+/wC1r8TU/wAwfIJP/wArH17/AJZtN/7h9p/1Ty38vHz+bjfyhk7o /J3/ACsfXv8Alm03/uH2n/VPH8vHz+a/yhk7o/J3/Kx9e/5ZtN/7h9p/1Tx/Lx8/mv8AKGTuj8nf 8rH17/lm03/uH2n/AFTx/Lx8/mv8oZO6Pyd/ysfXv+WbTf8AuH2n/VPH8vHz+a/yhk7o/JofmNrw FBbab/3D7T/qnj+Xj5/Nf5Qyd0fk3/ysfXv+WbTf+4faf9U8fy8fP5r/AChk7o/J3/Kx9e/5ZtN/ 7h9p/wBU8fy8fP5r/KGTuj8nf8rH17/lm03/ALh9p/1Tx/Lx8/mv8oZO6PyaH5ja8AALbTaDbfT7 Q/8AMvH8vHz+a/yhk7o/Jv8A5WPr3/LNpv8A3D7T/qnj+Xj5/Nf5Qyd0fk7/AJWPr3/LNpv/AHD7 T/qnj+Xj5/Nf5Qyd0fkirL83POVhz+ovaWokp6ghtLeMNxrSoVB45E6WB5382Ue08o5V8kV/yvD8 xf8Alui/6R4f+acH5PGn+Vc3l8n0F5O1G71PyrpWoXjB7q6tYpZnACguygk0GwzV5YgSID0WnmZY 4yPMgJpc/wBy30frytuVMVdiqncf3Y/10/4mMVVMVdirsVdiqld2sN3aTWsw5Q3EbRSr0qrgqw+4 4QaNoIsU+a/Mv5P6vpOpyW9vf2E0Fawma6ht5eB6c45WSh+VRm3x6sEbgvNZuy5xlsRXvpbD5e89 wwRW6app5ghXjHE9/ZOoG37LOQacRSvSm2A5MZ6H5FlHDqAABKNDzC2ex8/xi4gl1iykS65tOr6n YEN6go20kvh4dO2EHH3H5FjKOoFgyG/9KP6Uqh/L7XJV5Lc6bStP+OjZH/iMpyw6iI7/AJFojoJn rH/TBU/5Vxr3/LTpv/cQtP8Aqpg/MR8/ky/k/J3x+atZ/l1rqXcDm506iyKTTULQnZh29TBLURrr 8mWPQTEgbjz72S+atC85L5m1r9HanaW1ncXtxMsRv7WJqyqY25KzhlJQ0IyjHOHCLBuu5y8+HNxy 4ZAAnvHuS46X+YxuWuTrVl678g0n6QsqnkQx/b8VByfFj7j8i1+Hqbvij8wkv/KuNe/5adN/7iFp /wBVMt/MR8/k438n5O+Pzd/yrjXv+WnTf+4haf8AVTH8xHz+S/yfk74/N3/KuNe/5adN/wC4haf9 VMfzEfP5L/J+Tvj83f8AKuNe/wCWnTf+4haf9VMfzEfP5L/J+Tvj83f8q417/lp03/uIWn/VTH8x Hz+S/wAn5O+PzaX8udeIqLnTfp1C0H/MzH8xHz+S/wAn5O+Pzb/5Vxr3/LTpv/cQtP8Aqpj+Yj5/ Jf5Pyd8fm7/lXGvf8tOm/wDcQtP+qmP5iPn8l/k/J3x+bv8AlXGvf8tOm/8AcQtP+qmP5iPn8l/k /J3x+bQ/LnXiARc6bQ776haD/mZj+Yj5/Jf5Pyd8fm3/AMq417/lp03/ALiFp/1Ux/MR8/kv8n5O +Pzd/wAq417/AJadN/7iFp/1Ux/MR8/kv8n5O+Pza/5Vzr1SPrOm1G//AB0LTv8A89MfzEfP5L/J +Tvj82/+Vca9/wAtOm/9xC0/6qY/mI+fyX+T8nfH5vpPyRaS2flDR7WUo0kFpEjtG6yISqgfC6kq w9xmoym5k+b0unjw44g9AE3uP7lvo/XlbcqYq7FVOf7A/wBdP+JjFVTFXYq7FXYqhNYnubfSL6e1 HK6it5XgWnKsioSop33yURZFsZkgGnxvc3NxdXElzcyNNcTMXllclmZmNSST3zfgACg8TKRkbPNk tloXlKWztpZtTb6xIgM0KvEhUkpyI9QADhyb4GPx8aggHKZZJ2dnOhp8JiCZb+8fj9a9/L3lAWl9 IusLJcQPOLeFHA5qiExEGSOLmedA1KAg/D03HiTsbJ/L4aPq3F9fl0DEsyHXOxVEWH+91t/xlT/i QwS5FsxfWPez7zLoHlq/80eYbnUtbXTrpdSuo0tTHzLKq80avIU5P8G/35iY8khEAC9nZ5sGOeSR lLhPF+hJ7Ty55KlmZZvMLRRfWfQjkMS1MYWL96V57KWkfv0XLDkn/NaY6bCSbn1/Uxe8ihhvJ4oZ PWhjkdI5R+2qsQG+kb5fE2HAmAJEDko4WLsVdirsVdirsVdirsVdirsVdirsVdir63/Lv/lBdB/5 gYP+IDNFn+s+97LSf3Uf6oT24/uW+j9eVOQqYq7FVO4+wP8AXT/iYxVdWX+Vf+CP9MVdWX+Vf+CP 9MVdWX+Vf+CP9MVdWX+Vf+CP9MVdWX+Vf+CP9MVeXeZvIf5TXGqzSXc6WF47FriK2uCq8z1qnB1U +wpmXDUZQNnX5dBglKyKKU/8q5/J3/q6S/8ASQP+qOT/ADOXuav5N0/4KjN+Xf5Oh/8AjsXS7dEm DD7/AKu2EanL3BiezMHefmvh/Lr8nSv/AB1rht+rzhT93oLidTl7kjs3T+fzX/8AKufyd/6ukv8A 0kD/AKo4PzOXuT/Jun/BVIPy8/KBJ43j1SUyKwKD6wOoO3+6cTqcvcyj2dgBsfejfMHkX8rbzXL6 61LUZIr+aZ3uo1n4hZCasAPSNN/fIw1GQAADZll0GGcjKXM+aXf8q5/J3/q6S/8ASQP+qOS/M5e5 r/k3T/gu/wCVc/k7/wBXSX/pIH/VHH8zl7l/k3T/AILv+Vc/k7/1dJf+kgf9UcfzOXuX+TdP+C7/ AJVz+Tv/AFdJf+kgf9UcfzOXuX+TdP8Agu/5Vz+Tv/V0l/6SB/1Rx/M5e5f5N0/4Lv8AlXP5O/8A V0l/6SB/1Rx/M5e5f5N0/wCC0n5dfk+VBbVJQ3cfWB/1Sx/M5e5f5N0/4Lf/ACrn8nf+rpL/ANJA /wCqOP5nL3L/ACbp/wAFMdN/Jj8t9TiaWwubm4jRuDslwKBqVpvF75E6vIObIdl4Dyv5oz/lQPkn xu/+khf+qWD87PyT/JWHz+ayL8hPJTxI5N3VlBP79e4/4xY/nZ+S/wAlYfP5r/8AlQPknxu/+khf +qWP52fkv8lYfP5u/wCVA+SfG7/6SF/6pY/nZ+S/yVh8/msH5CeSjKyVu6BVP9+vcn/ir2x/Oz8l /krD5/Nf/wAqB8k+N3/0kL/1Sx/Oz8l/krD5/Nn2kaZHpWl2um2q1t7OJYYi71bigoKkKN8xpSMj Zc+EBGIiOQV7gy+i1VXt+0fH5ZFmq1l/lX/gj/TFXVl/lX/gj/TFVOcycFqq05p3P849hiqTazde dob5zpNlaXVgI/gWV2SYy8HY78uPHkqJ0/ar0GEUhCy335hmVjHptpGoCmOP1A67qvINIXjaoblU COg2ozY7Ksg1P8xHNus2j28fqMDcSLMjCNCzVH2viYLxGwp3r2B2VQvNd/MWzhnlOhQ3KIX9MRP8 XHk4jPBZJWYn4CQB440FTu0uPMFzoN1JeWq2WpFZhbxRPz7H0mr2J8MG1qeTwJ+fNudedTyr1r3r XM9wWc6SurSadDHHa2bRotqxlcuh+2DEWYLRtxyahNBUHKZVbfG6RcNj5lgcmOO3j9U3U4jd5XEb vxRwFEZqVapULXr77xsJopfqWiapd2yWcv1azJka5+KRypYqwb7MZUUWPl16EZISAYyiSxTUdPms LgQSsrsUWQMhJWjio3IGWg21SFKNr/vTF/rr+vCUDmyrXYPLT6vrT39xPHqC3k3pRp/dtGKEb8Ho xNRlUSaFNshGzaDW08jmpN7drtsvEHcqKb8B0brt06Ybkiod6laWvlD0iLy8uPWBkFYh8BAI9Mjl Hy3H+YwkyQBFEC18g8ZCby9BAPprRd6haf7r8a16e2C5JqCD1S38qx2rnTrq4muQwCLIKKRVuR+w v7PHv1rthBl1RIR6JNk2t2KuxV2KvWfyf/44d7/zE/8AMtcxs/NysHJnuUNynb/7zxf6i/qxVUxV 2Kqa/wC9D/6ifrbFVTFXYqp3H9y3fp+vFVTFXYqpz/YH+un/ABMYqqYq7FXYq7FVssscMTyyMFjj Us7HoFUVJxV43rnnDy9e6jLPH5fglVj/AH0jujv/AJTCMqKn6cy4wIHNxZZATyRttAs1nFcReXrP 0X9P0x9YuK/vmCjYE0py+LIk+bIDbkppaR3MriPSbCN4nmhdXuL0cTB8TmoZV40IIw3XVavohbi5 s9OtBPPodoR6zQqFnuuVVUGo5Mdqe+EC+qDt0QTeZNEY1by9bMfEzTn/AI2w8B72PGO5db+YdCM8 YHl22BLKAfVn23/1sTE96iY7kf5l13RofMGoRS6FbzyJPIrzNJMGchvtEBqb5GETQ3TOQvkln+It B/6ly2/5Gz/81ZLhPex4x3O/xFoP/UuW3/I2f/mrHhPevGO53+ItB/6ly2/5Gz/81Y8J714x3O/x FoP/AFLlt/yNn/5qx4T3rxjud/iLQf8AqXLb/kbP/wA1Y8J714x3O/xFoP8A1Llt/wAjZ/8AmrHh PevGO5y+YdCAofLtsT4mWf8A5qx4T3rxjud/iLQf+pctv+Rs/wDzVjwnvXjHc9G/LO+s7zSbp7Wx jsEWfi0cTOwY8FPIlyTlGUUW/EQQzDKm1Ttv954v9Rf1YqqYq7FVNf8Aeh/9RP1tiqpirsVU7n+5 b6P14qqYq7FVO4/ux/rp/wATGKqmKuxV2KuxVSvLZLq0ntnJCTxtGxHUB1Kn9eEFS8O1DyH5ps7p 4PqEtwqn4JoVLow7EU6fI5mDJEuGccgnNhoEkVugudH1FpAsYKIsqgkH97yIelGX4V4gUB3yBl5h sEfIoh9HswyB9F1WT93Irs0Vw1SSAhfjKK/AKECg/gOI94Wh3FZ+h4pOCtoWpzwAbpcLOCGAYgji 9P2lT7PRceLzC8PkUj1PynrD3INho93HBwQFTG5+MD4t2qeuTEx1LCUD0Chb+UfM63EROl3IAdST 6bePywmce9AhLuZJq0XnS31bVIrDTppLO4u5plcROeXqKY6qykfs9CP65XHhoWWw8QJoKK3X5gLM Jhop9UGvM27mo5B6UJp/eIr7dx4bYaj3oufc0Lr8xBC0K6S6qwmBP1dif9IdpHNWr+05pjUO9bn3 L4738wYldYtFKK7O21s5IMhJehJJ3Lt377Y1HvW59zU17+YspBOkulHD/Bbsu4ptseh4io9sah3r c+5C6inn7ULBrK40qUwswaogYNUcejeHwjb+AFCOEG7QeMiqSb/CHmn/AKtVz/yKb+mT4497Dw5d zh5R80EVGl3JHj6bf0x4496+HLud/hDzT/1arn/kU39MeOPevhy7npn5XaZqGn6RdxX1vJbSPccl SVSpK8FFRXMbMQTs5GIEDdmeVNqnbf7zxf6i/qxVUxV2Kqa/70P/AKifrbFVTFXYqp3H9y30frxV UxV2Kqc/2B/rp/xMYqqYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWl40+GlO1OmKt 4q7FXYq0vHiONONPhp0p7Yq3irsVa+HkenKgr403pireKuxVpuNPipTvXpireKuxVpuNPipSo6+N dvxxV//Z xmp.iid:c6a28c7d-5214-4971-ba3c-26045228c1e6 xmp.did:c6a28c7d-5214-4971-ba3c-26045228c1e6 uuid:5D20892493BFDB11914A8590D31508C8 default xmp.iid:920ba799-0fb3-4e68-a94e-bb7e83ad7ada xmp.did:920ba799-0fb3-4e68-a94e-bb7e83ad7ada uuid:5D20892493BFDB11914A8590D31508C8 default saved xmp.iid:44433185-2184-4731-93c4-278700048922 2019-11-26T15:11:19+01:00 Adobe Illustrator CC 2017 (Macintosh) / saved xmp.iid:c6a28c7d-5214-4971-ba3c-26045228c1e6 2020-02-05T10:20:37+01:00 Adobe Illustrator 24.0 (Macintosh) / Print Adobe Illustrator False True 1 35.326901 13.049515 Centimeters Cyan Magenta Yellow Black Groupe de nuances par défaut 0 Blanc CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Noir CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 Rouge CMJN CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 Jaune CMJN CMYK PROCESS 0.000000 0.000000 100.000000 0.000000 Vert CMJN CMYK PROCESS 100.000000 0.000000 100.000000 0.000000 Cyan CMJN CMYK PROCESS 100.000000 0.000000 0.000000 0.000000 Bleu CMJN CMYK PROCESS 100.000000 100.000000 0.000000 0.000000 Magenta CMJN CMYK PROCESS 0.000000 100.000000 0.000000 0.000000 C=15 M=100 J=90 N=10 CMYK PROCESS 15.000000 100.000000 90.000000 10.000000 C=0 M=90 J=85 N=0 CMYK PROCESS 0.000000 90.000000 85.000000 0.000000 C=0 M=80 J=95 N=0 CMYK PROCESS 0.000000 80.000000 95.000000 0.000000 C=0 M=50 J=100 N=0 CMYK PROCESS 0.000000 50.000000 100.000000 0.000000 C=0 M=35 J=85 N=0 CMYK PROCESS 0.000000 35.000000 85.000000 0.000000 C=5 M=0 J=90 N=0 CMYK PROCESS 5.000000 0.000000 90.000000 0.000000 C=20 M=0 J=100 N=0 CMYK PROCESS 20.000000 0.000000 100.000000 0.000000 C=50 M=0 J=100 N=0 CMYK PROCESS 50.000000 0.000000 100.000000 0.000000 C=75 M=0 J=100 N=0 CMYK PROCESS 75.000000 0.000000 100.000000 0.000000 C=85 M=10 J=100 N=10 CMYK PROCESS 85.000000 10.000000 100.000000 10.000000 C=90 M=30 J=95 N=30 CMYK PROCESS 90.000000 30.000000 95.000000 30.000000 C=75 M=0 J=75 N=0 CMYK PROCESS 75.000000 0.000000 75.000000 0.000000 C=80 M=10 J=45 N=0 CMYK PROCESS 80.000000 10.000000 45.000000 0.000000 C=70 M=15 J=0 N=0 CMYK PROCESS 70.000000 15.000000 0.000000 0.000000 C=85 M=50 J=0 N=0 CMYK PROCESS 85.000000 50.000000 0.000000 0.000000 C=100 M=95 J=5 N=0 CMYK PROCESS 100.000000 95.000000 5.000000 0.000000 C=100 M=100 J=25 N=25 CMYK PROCESS 100.000000 100.000000 25.000000 25.000000 C=75 M=100 J=0 N=0 CMYK PROCESS 75.000000 100.000000 0.000000 0.000000 C=50 M=100 J=0 N=0 CMYK PROCESS 50.000000 100.000000 0.000000 0.000000 C=35 M=100 J=35 N=10 CMYK PROCESS 35.000000 100.000000 35.000000 10.000000 C=10 M=100 J=50 N=0 CMYK PROCESS 10.000000 100.000000 50.000000 0.000000 C=0 M=95 J=20 N=0 CMYK PROCESS 0.000000 95.000000 20.000000 0.000000 C=25 M=25 J=40 N=0 CMYK PROCESS 25.000000 25.000000 40.000000 0.000000 C=40 M=45 J=50 N=5 CMYK PROCESS 40.000000 45.000000 50.000000 5.000000 C=50 M=50 J=60 N=25 CMYK PROCESS 50.000000 50.000000 60.000000 25.000000 C=55 M=60 J=65 N=40 CMYK PROCESS 55.000000 60.000000 65.000000 40.000000 C=25 M=40 J=65 N=0 CMYK PROCESS 25.000000 40.000000 65.000000 0.000000 C=30 M=50 J=75 N=10 CMYK PROCESS 30.000000 50.000000 75.000000 10.000000 C=35 M=60 J=80 N=25 CMYK PROCESS 35.000000 60.000000 80.000000 25.000000 C=40 M=65 J=90 N=35 CMYK PROCESS 40.000000 65.000000 90.000000 35.000000 C=40 M=70 J=100 N=50 CMYK PROCESS 40.000000 70.000000 100.000000 50.000000 C=50 M=70 J=80 N=70 CMYK PROCESS 50.000000 70.000000 80.000000 70.000000 Gris 1 C=0 M=0 J=0 N=100 CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 C=0 M=0 J=0 N=90 CMYK PROCESS 0.000000 0.000000 0.000000 89.999400 C=0 M=0 J=0 N=80 CMYK PROCESS 0.000000 0.000000 0.000000 79.998800 C=0 M=0 J=0 N=70 CMYK PROCESS 0.000000 0.000000 0.000000 69.999700 C=0 M=0 J=0 N=60 CMYK PROCESS 0.000000 0.000000 0.000000 59.999100 C=0 M=0 J=0 N=50 CMYK PROCESS 0.000000 0.000000 0.000000 50.000000 C=0 M=0 J=0 N=40 CMYK PROCESS 0.000000 0.000000 0.000000 39.999400 C=0 M=0 J=0 N=30 CMYK PROCESS 0.000000 0.000000 0.000000 29.998800 C=0 M=0 J=0 N=20 CMYK PROCESS 0.000000 0.000000 0.000000 19.999700 C=0 M=0 J=0 N=10 CMYK PROCESS 0.000000 0.000000 0.000000 9.999100 C=0 M=0 J=0 N=5 CMYK PROCESS 0.000000 0.000000 0.000000 4.998800 Couleurs vives 1 C=0 M=100 J=100 N=0 CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 C=0 M=75 J=100 N=0 CMYK PROCESS 0.000000 75.000000 100.000000 0.000000 C=0 M=10 J=95 N=0 CMYK PROCESS 0.000000 10.000000 95.000000 0.000000 C=85 M=10 J=100 N=0 CMYK PROCESS 85.000000 10.000000 100.000000 0.000000 C=100 M=90 J=0 N=0 CMYK PROCESS 100.000000 90.000000 0.000000 0.000000 C=60 M=90 J=0 N=0 CMYK PROCESS 60.000000 90.000000 0.003100 0.003100 Adobe PDF library 15.00

OCS-01: A potential paradigm
shift in DME treatment

One of our most advanced product candidates, OCS-01, is in phase 2 clinical development for DME and also for Pain and inflammation following ocular surgery. The Phase 2 trial in DME (DX-211) with 144 patients was successfully completed providing the first proof-of-concept for a topical drug effect on a chronic retinal disease.

 

OCS-01 has been developed from Oculis’ solubilizing nanoparticle (SNP) technology, a proprietary platform that enables the formulation of drugs as non-invasive topical treatments and enhances their bioavailability in the relevant eye tissues. If approved in DME, it has the potential to provide a new option for patients.

OCS-01: A potential treatment
for Post-cataract Surgery Inflammation

 

Because patients undergoing cataract surgery are usually on several medications daily, adding more eye drops can be challenging. A long-acting topical solution such as OCS-01 has the potential of reducing the frequency of the burden of administration to patients.

OCS-02: THE POTENTIAL OF
topical anti-TNF alpha
therapy for ophthalmic
indications

The compound, named OCS-02, is based on a proprietary single-chain antibody fragment technology specifically designed for topical delivery. Efficacy and safety were evaluated in three clinical trials including two controlled studies under IND. The studies demonstrated a promising profile for treating inflammatory conditions of the anterior segment of the eye including Uveitis and Dry Eye Disease.